Drug Shortage Report for RIVA-PYRIDOSTIGMINE

Last updated on 2021-03-31 History
Report ID 133116
Drug Identification Number 02495643
Brand name RIVA-PYRIDOSTIGMINE
Common or Proper name Riva-Pyridostigmine
Company Name LABORATOIRE RIVA INC.
Market Status MARKETED
Active Ingredient(s) PYRIDOSTIGMINE BROMIDE
Strength(s) 60MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N07AA
ATC description PARASYMPATHOMIMETICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2021-03-15
Actual start date
Estimated end date 2021-04-16
Actual end date 2021-03-30
Shortage status Resolved
Updated date 2021-03-31
Company comments Product under allocation
Health Canada comments
Tier 3 Status No
Contact Address 660 BOUL. INDUSTRIEL
BLAINVILLE, QUEBEC
CANADA J7C 3V4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-03-31 English Compare
v8 2021-03-30 French Compare
v7 2021-03-30 English Compare
v6 2021-03-16 English Compare
v5 2021-03-02 French Compare
v4 2021-03-02 English Compare
v3 2021-03-02 English Compare
v2 2021-02-02 French Compare
v1 2021-02-02 English Compare

Showing 1 to 9 of 9